ArticleBMJ open diabetes research & care2024

Assessing the use of sodium-glucose cotransporter 2 inhibitor in patients with type 2 diabetes mellitus and chronic kidney disease in tertiary care: a SwissDiab Study.

Pascale Sharon Hösli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.